EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Chemopreventive and Anticancer Role of Resveratrol against Oral Squamous Cell Carcinoma

Giuseppe Angellotti iD, Giulia Di Prima iD, Elena Belfiore iD, Giuseppina Campisi iD, Viviana De Caro iD

Pharmaceutics · 13.01.2023 · 15 (1) · 275

DOI: 10.3390/pharmaceutics15010275 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pharmaceutics, online erschienen am 13.01.2023. Verfasst von Giuseppe Angellotti und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgical, Oncological and Oral Sciences, University of Palermo, Via L. Giuffrè 5, 90127 Palermo, Italy. Die Arbeit wurde bisher 55-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministero dell'Università e della Ricerca, PON FSE REACT-EU Research and Innovation 2014-2020, Ministero dell'Università e della Ricerca PON FSE-FESR R&I 2014-2020, Ministero dell'Università e della Ricerca, PNRR-M4C2, project "SiciliAn MicronanOTecH Research And Innovation CEnter -SAMOTHRACE".

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Oral squamous cell carcinoma (OSCC) is one of the most prevailing and aggressive head and neck cancers, featuring high morbidity and mortality. The available conventional treatments suffer from several adverse effects and are often inefficient in terms of their survival rates. Thus, seeking novel therapeutic agents and adjuvants is of the utmost importance for modern society. Natural polyphenolic compounds have recently emerged as promising chemopreventive and anticancer agents. Specifically, the natural compound resveratrol (RSV) has recently gained momentum for this purpose. RSV is useful for treating OSCC due to its antiproliferative, antimetastatic, and proapoptotic effects. Additionally, RSV acts against tumor cells while synergically cooperating with chemotherapeutics, overcoming drug resistance phenomena. Despite these wide-spectrum effects, there are few specific investigations regarding RSV’s effects against OSCC animal models that consider different routes and vehicles for the administration of RSV. Interestingly, an injectable RSV-loaded liposome-based formulation was proven to be effective against both in vitro and in vivo OSCC models, demonstrating that the development of RSV-loaded drug delivery systems for systemic and/or loco-regional applications may be the turning point in oral cancer treatment, leading to benefits from both RSV’s properties as well as from targeted delivery. Given these premises, this review offers a comprehensive overview of the in vitro and in vivo effects of RSV and its main derivative, polydatin (PD), against OSCC-related cell lines and animal models, aiming to guide the scientific community in regard to RSV and PD use in the treatment of oral precancerous and cancerous lesions.

Schlagwörter

Stichwörter der Autor:innen

adjuvantanticancerantimetastaticchemopreventionnatural compoundoral squamous cell carcinomapolydatinpolyphenolsresveratrol

Autor:innen und Institutionen

  • Department of Surgical, Oncological and Oral Sciences, University of Palermo, Via L. Giuffrè 5, 90127 Palermo, Italy.
  • Department of Biological, Chemical and Pharmaceutical Sciences and Technologies, University of Palermo, Via Archirafi 32, 90123 Palermo, Italy.

ORCID-Profile: Giuseppe Angellotti, Giulia Di Prima, Elena Belfiore, Giuseppina Campisi, Viviana De Caro

Förderung

  • Ministero dell'Università e della Ricerca, PON FSE REACT-EU Research and Innovation 2014-2020
  • Ministero dell'Università e della Ricerca PON FSE-FESR R&I 2014-2020
  • Ministero dell'Università e della Ricerca, PNRR-M4C2, project "SiciliAn MicronanOTecH Research And Innovation CEnter -SAMOTHRACE"
  • Ministero dell’Università e della Ricerca
  • Action IV.5 “Dottorati su tematiche green”
  • Action IV.6 “Contratti di ricerca su tematiche Green”
  • Action I.1, “Dottorati innovativi a caratterizzazione industriale”
  • SiciliAn MicronanOTecH Research And Innovation CEnter -SAMOTHRACE

Zitieren

APA

Angellotti, G., Di Prima, G., Belfiore, E., Campisi, G., & De Caro, V. (2023). Chemopreventive and Anticancer Role of Resveratrol against Oral Squamous Cell Carcinoma. Pharmaceutics, 15(1), 275. https://doi.org/10.3390/pharmaceutics15010275

Vancouver

Angellotti G, Di Prima G, Belfiore E, Campisi G, De Caro V. Chemopreventive and Anticancer Role of Resveratrol against Oral Squamous Cell Carcinoma. Pharmaceutics. 2023;15(1):275. doi:10.3390/pharmaceutics15010275

BibTeX
@article{Angellotti2023,
  author = {Angellotti, Giuseppe and Di Prima, Giulia and Belfiore, Elena and Campisi, Giuseppina and De Caro, Viviana},
  title = {Chemopreventive and Anticancer Role of Resveratrol against Oral Squamous Cell Carcinoma},
  journal = {Pharmaceutics},
  year = {2023},
  volume = {15},
  number = {1},
  pages = {275},
  doi = {10.3390/pharmaceutics15010275}
}
Kostenlos starten →